Search
  • All Journals
Advanced Search
Search articles by Title, Author, Keywords, DOI
Submit Manuscript
0.7Impact Factor
Advanced Search
MAP  >  Gastrointestinal Tumors
2021 Volume 8
Article Contents
Next Previous
REVIEW ARTICLE   Open Access    

Hepatic Arterial Infusion Chemotherapy Is a Feasible Treatment Option for Hepatocellular Carcinoma: A New Update

  • a.

    Department of Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China

  • b.

    Department of Surgery, Zhejiang Provincial Peoples Hospital, Hangzhou, China

More Information
  • Background: Hepatic arterial infusion chemotherapy (HAIC) is one option for treating massive tumors and unresectable hepatocellular carcinoma (HCC). However, there is a lack of remedial treatment after these treatments are ineffective or failed.
    Summary: Some studies have discovered that HAIC has greater survival in patients with advanced HCC. A previous study has shown that HAIC is effective in the treatment of advanced HCC, and the data on randomized clinical trials are limited and unclear.
    Key Message:: More clinical trials and research are needed in order to make HAIC a standard and recommended therapy for advanced HCC. Our review focuses on the clinical applications of hepatic artery infusion treatment.

  • Cite this article

    Maher Hendi, Yiping Mou, Jiemin Lv, Bin Zhang, Xiujun Cai. 2021. Hepatic Arterial Infusion Chemotherapy Is a Feasible Treatment Option for Hepatocellular Carcinoma: A New Update. Gastrointestinal Tumors. 8:5 doi: 10.1159/000516405
    Maher Hendi, Yiping Mou, Jiemin Lv, Bin Zhang, Xiujun Cai. 2021. Hepatic Arterial Infusion Chemotherapy Is a Feasible Treatment Option for Hepatocellular Carcinoma: A New Update. Gastrointestinal Tumors. 8:5 doi: 10.1159/000516405
    shu

Tables(1)

Download PDF

Article Metrics

Article views(917) PDF downloads(534)

Other Articles By Authors

Review Article   Open Access    

Hepatic Arterial Infusion Chemotherapy Is a Feasible Treatment Option for Hepatocellular Carcinoma: A New Update

  • a.

    Department of Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China

  • b.

    Department of Surgery, Zhejiang Provincial Peoples Hospital, Hangzhou, China

  • Received: 26 January 2021
  • Accepted: 28 March 2021
  • Published online: 15 July 2021
Gastrointestinal Tumors  8,  Article number: 10.1159/000516405  (2021)  |  Cite this article

Abstract: 

Background: Hepatic arterial infusion chemotherapy (HAIC) is one option for treating massive tumors and unresectable hepatocellular carcinoma (HCC). However, there is a lack of remedial treatment after these treatments are ineffective or failed.
Summary: Some studies have discovered that HAIC has greater survival in patients with advanced HCC. A previous study has shown that HAIC is effective in the treatment of advanced HCC, and the data on randomized clinical trials are limited and unclear.
Key Message:: More clinical trials and research are needed in order to make HAIC a standard and recommended therapy for advanced HCC. Our review focuses on the clinical applications of hepatic artery infusion treatment.

  • About this article
    Cite this article
    Maher Hendi, Yiping Mou, Jiemin Lv, Bin Zhang, Xiujun Cai. 2021. Hepatic Arterial Infusion Chemotherapy Is a Feasible Treatment Option for Hepatocellular Carcinoma: A New Update. Gastrointestinal Tumors. 8:5 doi: 10.1159/000516405
    Maher Hendi, Yiping Mou, Jiemin Lv, Bin Zhang, Xiujun Cai. 2021. Hepatic Arterial Infusion Chemotherapy Is a Feasible Treatment Option for Hepatocellular Carcinoma: A New Update. Gastrointestinal Tumors. 8:5 doi: 10.1159/000516405
    shu

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return